These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
484 related items for PubMed ID: 29423774
1. Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial [corrected]. Abdin A, Pöss J, Fuernau G, Ouarrak T, Desch S, Eitel I, de Waha S, Zeymer U, Böhm M, Thiele H. Clin Res Cardiol; 2018 Jun; 107(6):517-523. PubMed ID: 29423774 [Abstract] [Full Text] [Related]
2. "Smoker's paradox" in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry. Saad M, Fuernau G, Desch S, Eitel I, Jung C, Pöss J, Schneider S, Schuler G, Werdan K, Zeymer U, Thiele H. Int J Cardiol; 2016 Nov 01; 222():775-779. PubMed ID: 27521557 [Abstract] [Full Text] [Related]
9. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, Dens J, Dzavik V, Palmeri ST, Webb JG, Goldberger M, Hochman JS. J Am Coll Cardiol; 2000 Sep 01; 36(3 Suppl A):1123-9. PubMed ID: 10985715 [Abstract] [Full Text] [Related]
10. Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy. Jung C, Fuernau G, de Waha S, Eitel I, Desch S, Schuler G, Figulla HR, Thiele H. Clin Res Cardiol; 2015 Aug 01; 104(8):679-87. PubMed ID: 25720332 [Abstract] [Full Text] [Related]
11. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Böhm M, Kurowski V, Lauer B, Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Möllmann H, Schneider S, Ebelt H, Werdan K, Zeymer U. Am Heart J; 2012 Jun 01; 163(6):938-45. PubMed ID: 22709745 [Abstract] [Full Text] [Related]
14. Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock--a biomarker substudy of the IABP-SHOCK II-Trial. Pöss J, Fuernau G, Denks D, Desch S, Eitel I, de Waha S, Link A, Schuler G, Adams V, Böhm M, Thiele H. Eur J Heart Fail; 2015 Nov 01; 17(11):1152-60. PubMed ID: 26333723 [Abstract] [Full Text] [Related]
15. Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial. Fengler K, Fuernau G, Desch S, Eitel I, Neumann FJ, Olbrich HG, de Waha A, de Waha S, Richardt G, Hennersdorf M, Empen K, Hambrecht R, Fuhrmann J, Böhm M, Poess J, Strasser R, Schneider S, Schuler G, Werdan K, Zeymer U, Thiele H. Clin Res Cardiol; 2015 Jan 01; 104(1):71-8. PubMed ID: 25287767 [Abstract] [Full Text] [Related]